The global Oligosaccharides in Infant Nutrition Market Comprehensive Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments -By Type (Powder, Liquid, Others), By Application (Food, Health Products, Drinks, Medicine, Others)
The Oligosaccharides in the Infant Nutrition Market involves the production and incorporation of oligosaccharides in infant formulas to mimic the prebiotic benefits of human milk. These ingredients support gut health and immune function in infants. The market is driven by increasing awareness about the benefits of prebiotics, rising demand for high-quality infant nutrition products, and advancements in food science and technology. Additionally, the growth of the infant formula market and increasing consumer preference for products that support infant health contribute to market growth.
The market report analyses the leading companies in the industry including Abbot, Biosynth Carbosynth, Dextra Laboratories Ltd, DuPont de Nemours Inc, Inbiose NV, Ingredion Inc, Jennewein Biotechnologie GmbH, Kerry Group plc, Nissin Sugar Co. Ltd, Royal FrieslandCampina N.V., Taiwan Fructose, Tereos, Yakult Pharmaceutical Co. Ltd, Zuchem, and Others.
The most prominent trend in the Oligosaccharides in the Infant Nutrition Market is the focus on prebiotic ingredients. Oligosaccharides, which are prebiotic compounds, play a crucial role in promoting gut health and supporting the growth of beneficial bacteria in infants. This trend is driven by the increasing awareness of the importance of gut health in early childhood development. Manufacturers are incorporating oligosaccharides into infant formulas and baby foods to provide additional health benefits and meet the growing demand for functional nutrition products
The rising incidence of digestive disorders in infants is a major driver of the Oligosaccharides in the Infant Nutrition Market. Digestive issues such as colic, constipation, and diarrhea are common in infants, leading parents to seek nutritional solutions that can alleviate these problems. Oligosaccharides, with their prebiotic properties, help improve digestive health and support a healthy gut microbiome. The growing prevalence of digestive disorders and the desire for effective nutritional interventions are driving the demand for oligosaccharide-enriched infant nutrition products
A significant opportunity in the Oligosaccharides in the Infant Nutrition Market lies in innovation in infant nutrition formulations. As research on the benefits of oligosaccharides continues to evolve, there is potential for the development of new and improved infant nutrition products. This includes exploring different types of oligosaccharides, combining them with other functional ingredients, and creating specialized formulations for specific health needs. By investing in research and development, companies can introduce innovative products that cater to the diverse nutritional requirements of infants
The powder segment is expected to be the fastest-growing in the Oligosaccharides in the Infant Nutrition Market by type to 2032. Powdered oligosaccharides are widely used in infant formula and other nutritional products due to their stability, ease of storage, and longer shelf life. The demand for powdered oligosaccharides is driven by the increasing awareness of the health benefits of oligosaccharides, including their role in promoting gut health and supporting the immune system. Additionally, the growing trend of clean label and organic products in the infant nutrition market contributes to the segment's rapid growth. The expansion of the infant formula market and the increasing use of powdered oligosaccharides in various formulations support the growth of this segment.
The health products segment is anticipated to be the fastest-growing in the Oligosaccharides in the Infant Nutrition Market by application to 2032. The demand for oligosaccharides in health products is driven by the increasing focus on promoting gut health and overall well-being in infants. Oligosaccharides are used in various health products, including supplements and functional foods, to support the development of a healthy gut microbiome and enhance immune function. Additionally, the growing awareness of the long-term health benefits of oligosaccharides and the rising trend of preventive healthcare contribute to the segment's rapid growth. The expansion of the health products market and the increasing incorporation of oligosaccharides in various formulations support the growth of this segment.
By Type
Powder
Liquid
Others
By Application
Food
Health Products
Drinks
Medicine
Others
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Abbot
Biosynth Carbosynth
Dextra Laboratories Ltd
DuPont de Nemours Inc
Inbiose NV
Ingredion Inc
Jennewein Biotechnologie GmbH
Kerry Group plc
Nissin Sugar Co. Ltd
Royal FrieslandCampina N.V.
Taiwan Fructose
Tereos
Yakult Pharmaceutical Co. Ltd
Zuchem
*- List Not Exhaustive
Chapter 1. TABLE OF CONTENTS
Chapter 2. Introduction to Oligosaccharides in Infant Nutrition Market
2.1. Market Overview
2.2. Key Statistics and Report Highlights
2.3. Scope of the Comprehensive Study
2.3.1. Market Definition
2.3.2 Countries and Regions Covered
2.3.3 Research Objective
2.3.4 Units, Currency, and Conversions
2.3.5 Industry Value Chain
2.4. Key Market Segments
2.5. Key Companies
2.6. Study Period
Chapter 3. Strategic Analysis Review
3.1. Oligosaccharides in Infant Nutrition Pricing Analysis and Forecast
3.2. Porter’s Five Forces
3.3. Market Ecosystem
3.4. SWOT Analysis
3.5. Regulatory Scenario
3.3. Effects of Inflation, Russia-Ukraine War, moderating economic growth, and other macroeconomic factors
Chapter 4. Competitive Landscape
4.1. Market Share Analysis
4.1.1. Global Oligosaccharides in Infant Nutrition Market Share by Company, 2023
4.1.2. Product Offerings of Leading Oligosaccharides in Infant Nutrition Companies
4.2. Market Entropy
4.2.1. New Product Launches in the Industry
4.2.2. Mergers, Acquisitions, Joint ventures, and Partnerships
4.3. Key Strategies and Best Practices
Chapter 5. Global Market Projections: Best, Reference, and Low Case Scenarios
5.1. Growth Analysis- Case Scenario Definitions
5.2. Low Growth Case Scenario Forecasts
5.3. Reference Growth Case Scenario Forecasts
5.4. High Growth Case Scenario Forecasts
Chapter 6. Market Dynamics
6.1. Oligosaccharides in Infant Nutrition Market Drivers
6.2. Oligosaccharides in Infant Nutrition Market Challenges
6.6. Oligosaccharides in Infant Nutrition Market Opportunities
6.4. Oligosaccharides in Infant Nutrition Market Trends
Chapter 7. Global Oligosaccharides in Infant Nutrition Market Outlook Trends
7.1. Global Oligosaccharides in Infant Nutrition Revenue (USD Million) and CAGR (%) by Type (2021-2032)
7.2. Global Oligosaccharides in Infant Nutrition Revenue (USD Million) and CAGR (%) by Application (2021-2032)
7.3. Global Oligosaccharides in Infant Nutrition Revenue (USD Million) and CAGR (%) by Product (2021-2032)
By Type
Powder
Liquid
Others
By Application
Food
Health Products
Drinks
Medicine
Others
Chapter 8. Global Oligosaccharides in Infant Nutrition Regional Analysis and Outlook
8.1. Global Oligosaccharides in Infant Nutrition Revenue (USD Million) By Regions (2021- 2032)
8.2. North America Oligosaccharides in Infant Nutrition Revenue (USD Million) by Country (2021-2032)
8.2.1. United States Oligosaccharides in Infant Nutrition Regional Analysis and Outlook
8.2.2. Canada Oligosaccharides in Infant Nutrition Regional Analysis and Outlook
8.2.3. Mexico Oligosaccharides in Infant Nutrition Regional Analysis and Outlook
8.3. Europe Oligosaccharides in Infant Nutrition Revenue (USD Million), by Country (2021-2032)
8.3.1. Germany Oligosaccharides in Infant Nutrition Regional Analysis and Outlook
8.3.2. France Oligosaccharides in Infant Nutrition Regional Analysis and Outlook
8.3.3. United Kingdom Oligosaccharides in Infant Nutrition Regional Analysis and Outlook
8.3.4. Spain Oligosaccharides in Infant Nutrition Regional Analysis and Outlook
8.3.5. Italy Oligosaccharides in Infant Nutrition Regional Analysis and Outlook
8.3.6. Russia Oligosaccharides in Infant Nutrition Regional Analysis and Outlook
8.3.7. Rest of Europe Oligosaccharides in Infant Nutrition Regional Analysis and Outlook
8.4. Asia Pacific Oligosaccharides in Infant Nutrition Revenue (USD Million) by Country (2021-2032)
8.4.1. China Oligosaccharides in Infant Nutrition Regional Analysis and Outlook
8.4.2. Japan Oligosaccharides in Infant Nutrition Regional Analysis and Outlook
8.4.3. India Oligosaccharides in Infant Nutrition Regional Analysis and Outlook
8.4.4. South Korea Oligosaccharides in Infant Nutrition Regional Analysis and Outlook
8.4.5. Australia Oligosaccharides in Infant Nutrition Regional Analysis and Outlook
8.4.6. South East Asia Oligosaccharides in Infant Nutrition Regional Analysis and Outlook
8.4.7. Rest of Asia Pacific Oligosaccharides in Infant Nutrition Regional Analysis and Outlook
8.5. South America Oligosaccharides in Infant Nutrition Revenue (USD Million), by Country (2021-2032)
8.5.1. Brazil Oligosaccharides in Infant Nutrition Regional Analysis and Outlook
8.5.2. Argentina Oligosaccharides in Infant Nutrition Regional Analysis and Outlook
8.5.3. Rest of South America Oligosaccharides in Infant Nutrition Regional Analysis and Outlook
8.6. Middle East and Africa Oligosaccharides in Infant Nutrition Revenue (USD Million) by Country (2021-2032)
8.6.1. Middle East Oligosaccharides in Infant Nutrition Regional Analysis and Outlook
8.6.2. Africa Oligosaccharides in Infant Nutrition Regional Analysis and Outlook
Chapter 9. North America Oligosaccharides in Infant Nutrition Analysis and Outlook
9.1. North America Oligosaccharides in Infant Nutrition Revenue (USD Million) by Segments (2021-2032)
9.1.1. North America Oligosaccharides in Infant Nutrition Revenue (USD Million) by Type (2021-2032)
9.1.2. North America Oligosaccharides in Infant Nutrition Revenue (USD Million) by Application (2021-2032)
9.1.3. North America Oligosaccharides in Infant Nutrition Revenue (USD Million) by Product (2021-2032)
By Type
Powder
Liquid
Others
By Application
Food
Health Products
Drinks
Medicine
Others
Chapter 10. Europe Oligosaccharides in Infant Nutrition Analysis and Outlook
10.1. Europe Oligosaccharides in Infant Nutrition Revenue (USD Million), by Segments (USD Million) (2021-2032)
10.1.1. Europe Oligosaccharides in Infant Nutrition Revenue (USD Million) by Type (2021-2032)
10.1.2. Europe Oligosaccharides in Infant Nutrition Revenue (USD Million) by Application (2021-2032)
10.1.3. Europe Oligosaccharides in Infant Nutrition Revenue (USD Million) by Product (2021-2032)
By Type
Powder
Liquid
Others
By Application
Food
Health Products
Drinks
Medicine
Others
Chapter 11. Asia Pacific Oligosaccharides in Infant Nutrition Analysis and Outlook
11.1. Asia Pacific Oligosaccharides in Infant Nutrition Revenue (USD Million), and Revenue (USD Million) by Segments (2021-2032)
11.1.1. Asia Pacific Oligosaccharides in Infant Nutrition Revenue (USD Million) by Type (2021-2032)
11.1.2. Asia Pacific Oligosaccharides in Infant Nutrition Revenue (USD Million) by Application (2021-2032)
11.1.3. Asia Pacific Oligosaccharides in Infant Nutrition Revenue (USD Million) by Product (2021-2032)
By Type
Powder
Liquid
Others
By Application
Food
Health Products
Drinks
Medicine
Others
Chapter 12. South America Oligosaccharides in Infant Nutrition Analysis and Outlook
12.1. South America Oligosaccharides in Infant Nutrition Revenue (USD Million), by Segments (2021-2032)
12.1.1. South America Oligosaccharides in Infant Nutrition Revenue (USD Million) by Type (2021-2032)
12.1.2. South America Oligosaccharides in Infant Nutrition Revenue (USD Million) by Application (2021-2032)
12.1.3. South America Oligosaccharides in Infant Nutrition Revenue (USD Million) by Product (2021-2032)
By Type
Powder
Liquid
Others
By Application
Food
Health Products
Drinks
Medicine
Others
Chapter 13. Middle East and Africa Oligosaccharides in Infant Nutrition Analysis and Outlook
13.1. Middle East and Africa Oligosaccharides in Infant Nutrition Revenue (USD Million), by Segments (2021-2032)
13.1.1. Middle East and Africa Oligosaccharides in Infant Nutrition Revenue (USD Million) by Type (2021-2032)
13.1.2. Middle East and Africa Oligosaccharides in Infant Nutrition Revenue (USD Million) by Application (2021-2032)
13.1.3. Middle East and Africa Oligosaccharides in Infant Nutrition Revenue (USD Million) by Product (2021-2032)
By Type
Powder
Liquid
Others
By Application
Food
Health Products
Drinks
Medicine
Others
Chapter 14. Oligosaccharides in Infant Nutrition Company Profiles
14.1 Business Overview
14.2 Product Profiles
14.3 SWOT Profiles
14.5 Recent Developments
14.6 Financial Profile
List of Companies
Abbot
Biosynth Carbosynth
Dextra Laboratories Ltd
DuPont de Nemours Inc
Inbiose NV
Ingredion Inc
Jennewein Biotechnologie GmbH
Kerry Group plc
Nissin Sugar Co. Ltd
Royal FrieslandCampina N.V.
Taiwan Fructose
Tereos
Yakult Pharmaceutical Co. Ltd
Zuchem
15. Methodology and Data Sources
15.1 Customization Offerings
15.2 Subscription Services
15.3 Related Reports
15.4 Publisher Expertise
LIST OF TABLES
Table 1 Market Segmentation Analysis
Table 2 Global Oligosaccharides in Infant Nutrition Market Share of Leading Companies, 2023
Table 3 Product Offerings of Leading Companies
Table 4 Low Growth Scenario Forecasts
Table 5 Reference Case Growth Scenario
Table 6 High Growth Case Scenario
Table 7 Global Oligosaccharides in Infant Nutrition Revenue (USD Million) And CAGR (%) By Type (2021-2032)
Table 8 Global Oligosaccharides in Infant Nutrition Revenue (USD Million) And CAGR (%) By Application (2021-2032)
Table 9 Global Oligosaccharides in Infant Nutrition Revenue (USD Million) And CAGR (%) By Product (2021-2032)
Table 10 Global Oligosaccharides in Infant Nutrition Market Revenue (USD Million) By Regions (2021-2032)
Table 11 Global Oligosaccharides in Infant Nutrition Market Share (%) By Regions (2021-2032)
Table 12 North America Oligosaccharides in Infant Nutrition Revenue (USD Million) By Country (2021-2032)
Table 13 Europe Oligosaccharides in Infant Nutrition Revenue (USD Million) By Country (2021-2032)
Table 14 Asia Pacific Oligosaccharides in Infant Nutrition Revenue (USD Million) By Country (2021-2032)
Table 15 South America Oligosaccharides in Infant Nutrition Revenue (USD Million) By Country (2021-2032)
Table 16 Middle East and Africa Oligosaccharides in Infant Nutrition Revenue (USD Million) By Region (2021-2032)
Table 17 North America Oligosaccharides in Infant Nutrition Revenue (USD Million) By Type (2021-2032)
Table 18 North America Oligosaccharides in Infant Nutrition Revenue (USD Million) By Application (2021-2032)
Table 19 North America Oligosaccharides in Infant Nutrition Revenue (USD Million) By Product (2021-2032)
Table 20 Europe Oligosaccharides in Infant Nutrition Revenue (USD Million) By Type (2021-2032)
Table 21 Europe Oligosaccharides in Infant Nutrition Revenue (USD Million) By Application (2021-2032)
Table 22 Europe Oligosaccharides in Infant Nutrition Revenue (USD Million) By Product (2021-2032)
Table 23 Asia Pacific Oligosaccharides in Infant Nutrition Revenue (USD Million) By Type (2021-2032)
Table 24 Asia Pacific Oligosaccharides in Infant Nutrition Revenue (USD Million) By Application (2021-2032)
Table 25 Asia Pacific Oligosaccharides in Infant Nutrition Revenue (USD Million) By Product (2021-2032)
Table 26 South America Oligosaccharides in Infant Nutrition Revenue (USD Million) By Type (2021-2032)
Table 27 South America Oligosaccharides in Infant Nutrition Revenue (USD Million) By Application (2021-2032)
Table 28 South America Oligosaccharides in Infant Nutrition Revenue (USD Million) By Product (2021-2032)
Table 29 Middle East and Africa Oligosaccharides in Infant Nutrition Revenue (USD Million) By Type (2021-2032)
Table 30 Middle East and Africa Oligosaccharides in Infant Nutrition Revenue (USD Million) By Application (2021-2032)
Table 31 Middle East and Africa Oligosaccharides in Infant Nutrition Revenue (USD Million) By Product (2021-2032)
LIST OF FIGURES
Figure 1. Market Scope
Figure 2. Pricing Forecasts Per Unit, 2023- 2032
Figure 3. Porter’s Five Forces
Figure 4. Global Oligosaccharides in Infant Nutrition Market Revenue (USD Million) By Regions (2021-2032)
Figure 5. Global Oligosaccharides in Infant Nutrition Market Share (%) By Regions (2023)
Figure 6. North America Oligosaccharides in Infant Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 7. United States Oligosaccharides in Infant Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 8. Canada Oligosaccharides in Infant Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 9. Mexico Oligosaccharides in Infant Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 10. Europe Oligosaccharides in Infant Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 11. Germany Oligosaccharides in Infant Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 12. France Oligosaccharides in Infant Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 13. United Kingdom Oligosaccharides in Infant Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 14. Spain Oligosaccharides in Infant Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 15. Italy Oligosaccharides in Infant Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 16. Russia Oligosaccharides in Infant Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 17. Rest of Europe Oligosaccharides in Infant Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 11. Asia Pacific Oligosaccharides in Infant Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 12. China Oligosaccharides in Infant Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 13. Japan Oligosaccharides in Infant Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 14. India Oligosaccharides in Infant Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 15. South Korea Oligosaccharides in Infant Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 16. Australia Oligosaccharides in Infant Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 17. South East Asia Oligosaccharides in Infant Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 18. South America Oligosaccharides in Infant Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 19. Brazil Oligosaccharides in Infant Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 20. Argentina Oligosaccharides in Infant Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 21. Rest of Asia Pacific Oligosaccharides in Infant Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 22. Middle East and Africa Oligosaccharides in Infant Nutrition Revenue (USD Million) By Region (2021-2032)
Figure 23. Saudi Arabia Oligosaccharides in Infant Nutrition Revenue (USD Million) By Region (2021-2032)
Figure 24. The UAE Oligosaccharides in Infant Nutrition Revenue (USD Million) By Region (2021-2032)
Figure 25. Rest of Middle East Oligosaccharides in Infant Nutrition Revenue (USD Million) By Region (2021-2032)
Figure 26. South Africa Oligosaccharides in Infant Nutrition Revenue (USD Million) By Region (2021-2032)
Figure 27. Africa Oligosaccharides in Infant Nutrition Revenue (USD Million) By Region (2021-2032)
Figure 28. North America Oligosaccharides in Infant Nutrition Revenue (USD Million) By Type (2021-2032)
Figure 29. North America Oligosaccharides in Infant Nutrition Revenue (USD Million) By Application (2021-2032)
Figure 30. North America Oligosaccharides in Infant Nutrition Revenue (USD Million) By Product (2021-2032)
Figure 31. Europe Oligosaccharides in Infant Nutrition Revenue (USD Million) By Type (2021-2032)
Figure 32. Europe Oligosaccharides in Infant Nutrition Revenue (USD Million) By Application (2021-2032)
Figure 33. Europe Oligosaccharides in Infant Nutrition Revenue (USD Million) By Product (2021-2032)
Figure 34. Asia Pacific Oligosaccharides in Infant Nutrition Revenue (USD Million) By Type (2021-2032)
Figure 35. Asia Pacific Oligosaccharides in Infant Nutrition Revenue (USD Million) By Application (2021-2032)
Figure 36. Asia Pacific Oligosaccharides in Infant Nutrition Revenue (USD Million) By Product (2021-2032)
Figure 37. South America Oligosaccharides in Infant Nutrition Revenue (USD Million) By Type (2021-2032)
Figure 38. South America Oligosaccharides in Infant Nutrition Revenue (USD Million) By Application (2021-2032)
Figure 39. South America Oligosaccharides in Infant Nutrition Revenue (USD Million) By Product (2021-2032)
Figure 40. Middle East and Africa Oligosaccharides in Infant Nutrition Revenue (USD Million) By Type (2021-2032)
Figure 41. Middle East and Africa Oligosaccharides in Infant Nutrition Revenue (USD Million) By Application (2021-2032)
Figure 42. Middle East and Africa Oligosaccharides in Infant Nutrition Revenue (USD Million) By Product (2021-2032)
By Type
Powder
Liquid
Others
By Application
Food
Health Products
Drinks
Medicine
Others
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Global Oligosaccharides in Infant Nutrition Market Size is valued at $164.7 Million in 2024 and is forecast to register a growth rate (CAGR) of 21.9% to reach $803 Million by 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Abbot, Biosynth Carbosynth, Dextra Laboratories Ltd, DuPont de Nemours Inc, Inbiose NV, Ingredion Inc, Jennewein Biotechnologie GmbH, Kerry Group plc, Nissin Sugar Co. Ltd, Royal FrieslandCampina N.V., Taiwan Fructose, Tereos, Yakult Pharmaceutical Co. Ltd, Zuchem
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2032; Currency: Revenue (USD); Volume